IDiyas

For the Inventor, By the Inventor

Yokohama, Japan

Tomizo Niwa

USPTO Granted Patents = 12

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 47(Granted Patents)


Location History:

  • Yokohama, JA (1976)
  • Yokohama, JP (1979 - 1985)

Company Filing History:

goldMedal12 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents

Years Active: 1976-1985

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4536398 - Antiviral agents (1985-08-20),
2. 4404218 - Antibiotic SF-2103A substance and process for production thereof (1983-09-13),
3. 4396603 - Novel antibiotic SF-2107 series substance and process for preparing the (1983-08-02),
4. 4376778 - Antibiotic substances and processes for production thereof (1983-03-15),
5. 4316894 - Antibiotic SF-1130-x.sub.3 3 substance and production and use thereof (1982-02-23),
6. 4298599 - Novel antibiotic BN-235 substance, and process for the production thereof (1981-11-03),
7. 4235883 - Novel antibiotic BN-213 substance and its production (1980-11-25),
8. 4226941 - Process for the optical resolution of (1980-10-07),
9. 4220639 - Antibiotics SF-2050 and SF-2050B substances and production and use (1980-09-02),
10. 4141790 - Process for the preparation of 7-amino-cephem compounds using mold fungi (1979-02-27),
11. 3975235 - Process for the production of cephamycin type antibiotic substances (1976-08-17),
12. 3956337 - Process for the preparation of D-gluconic-.delta.-lactam (1976-05-11),

Title: The Innovative Contributions of Tomizo Niwa

Introduction

Tomizo Niwa is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and antibiotic agents. With a total of 12 patents to his name, Niwa's work has had a substantial impact on medical science.

Latest Patents

One of his latest patents involves an antiviral agent that comprises a substance known as SF-2140, along with a pharmaceutically acceptable carrier. This invention also includes a method for treating viral diseases by administering a pharmaceutically effective amount of SF-2140. Another notable patent is for an antibiotic substance known as SF-2103A, which details a process for its production. This process involves cultivating a strain that produces the antibiotic in a nutrient medium and recovering the desired substance from the culture broth.

Career Highlights

Niwa has built a successful career at Meiji Seika Kaisha, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to breakthroughs in the treatment of various diseases, showcasing his dedication to improving public health.

Collaborations

Throughout his career, Niwa has collaborated with esteemed colleagues such as Takashi Shomura and Norio Ezaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Tomizo Niwa's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective treatments for viral and bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…